The Epidemiology of Atrial Fibrillation and Stroke

Cardiology Clinics

Volumn 34, Issue 2, 2016, Pages 255-268

  Pistoia, Francesca ^a   Sacco, Simona ^a   Tiseo, Cindy ^a   Degan, Diana ^a   Ornello, Raffaele ^a   Carolei, Antonio ^a  

^a UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

Atrial fibrillation; Cardioembolic stroke; Cryptogenic stroke; Epidemiology; Stroke

Indexed keywords

ANTERIOR MYOCARDIAL INFARCTION; ARTERY OCCLUSION; ATRIAL FIBRILLATION; BRAIN ATHEROSCLEROSIS; BRAIN ISCHEMIA; CARDIOEMBOLIC STROKE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; DISABILITY SEVERITY; DISEASE ASSOCIATION; HUMAN; INCIDENCE; LACUNAR STROKE; PRIORITY JOURNAL; REVIEW; THROMBOEMBOLISM; COMPLICATION; HEALTH; PREVALENCE; RISK FACTOR; STROKE;

ATRIAL FIBRILLATION; GLOBAL HEALTH; HUMANS; INCIDENCE; PREVALENCE; RISK FACTORS; STROKE;

EID: 85027946354     PISSN: 07338651     EISSN: 15582264     Source Type: Journal    
DOI: 10.1016/j.ccl.2015.12.002     Document Type: Review

References (100)

1. January, C.T., Wann, L.S., Alpert, J.S., et al. Yancy CW for the ACC/AHA task force members. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. Circulation 130 (2014), e199–e267.
2. Lip, G.Y., Tse, H.F., Lane, D.A., Atrial fibrillation. Lancet 379 (2012), 648–661.
3. Marini, C., De Santis, F., Sacco, S., et al. Contribution of atrial fibrillation to incidence and outcome of ischemic stroke: results from a population-based study. Stroke 36 (2005), 1115–1119.
4. Chugh, S.S., Havmoeller, R., Narayanan, K., et al. Worldwide epidemiology of atrial fibrillation: a global burden of disease 2010 study. Circulation 129 (2014), 837–847.
5. Colilla, S., Crow, A., Petkun, W., et al. Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S. adult population. Am J Cardiol 112 (2013), 1142–1147.
6. Stefansdottir, H., Aspelund, T., Gudnason, V., et al. Trends in the incidence and prevalence of atrial fibrillation in Iceland and future projections. Europace 13 (2011), 1110–1117.
7. Majeed, A., Moser, K., Carroll, K., Trends in the prevalence and management of atrial fibrillation in general practice in England and Wales, 1994–1998: analysis of data from the general practice research database. Heart 86 (2001), 284–288.
8. Barrios, V., Calderón, A., Escobar, C., et al., for the Primary Care Group in the Clinical Cardiology Section of the Spanish Society of Cardiology, Patients with atrial fibrillation in a primary care setting: Val-FAAP study. Rev Esp Cardiol 65 (2012), 47–53.
9. Heeringa, J., van der Kuip, D.A., Hofman, A., et al. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. Eur Heart J 27 (2006), 949–953.
10. Sturm, J.W., Davis, S.M., O'Sullivan, J.G., et al. The avoid stroke as soon as possible (ASAP) general practice stroke audit. Med J Aust 176 (2002), 312–316.
11. Habibzadeh, F., Yadollahie, M., Roshanipoor, M., et al. Prevalence of atrial fibrillation in a primary health care centre in Fars province, Islamic republic of Iran. East Mediterr Health J 10 (2004), 147–151.
12. Bonhorst, D., Mendes, M., Adragão, P., et al. Prevalence of atrial fibrillation in the Portuguese population aged 40 and over: the FAMA study. Rev Port Cardiol 29 (2010), 331–350.
13. Kawabata-Yoshihara, L.A., Benseñor, I.M., Kawabata, V.S., et al. Prevalence of electrocardiographic findings in elderly individuals: the São Paulo aging & health study. Arq Bras Cardiol 93 (2009), 602–607.
14. Wilke, T., Groth, A., Mueller, S., et al. Oral anticoagulation use by patients with atrial fibrillation in Germany. Adherence to guidelines, causes of anticoagulation under-use and its clinical outcomes, based on claims-data of 183,448 patients. Thromb Haemost 107 (2012), 1053–1065.
15. Friberg, L., Rosenqvist, M., Lip, G.Y., Net clinical benefit of warfarin in patients with atrial fibrillation: a report from the Swedish atrial fibrillation cohort study. Circulation 125 (2012), 2298–2307.
16. Charlemagne, A., Blacher, J., Cohen, A., et al. Epidemiology of atrial fibrillation in France: extrapolation of international epidemiological data to France and analysis of French hospitalization data. Arch Cardiovasc Dis 104 (2011), 115–124.
17. Naccarelli, G.V., Varker, H., Lin, J., et al. Increasing prevalence of atrial fibrillation and flutter in the United States. Am J Cardiol 104 (2009), 1534–1539.
18. Schmutz, M., Beer-Borst, S., Meiltz, A., et al. Low prevalence of atrial fibrillation in asymptomatic adults in Geneva, Switzerland. Europace 12 (2010), 475–481.
19. Chen, X., Wang, H., Zhang, H., et al. The prevalence survey and influential factors of atrial fibrillation in Taiyuan. Heart 97 (2011), A91–A92.
20. Shavadia, J., Yonga, G., Mwanzi, S., et al. Clinical characteristics and outcomes of atrial fibrillation and flutter at the Aga Khan University Hospital, Nairobi: cardiovascular topics. Cardiovasc J Afr 24 (2013), 6–9.
21. Kiatchoosakun, S., Pachirat, O., Chirawatkul, A., et al. Prevalence of cardiac arrhythmias in Thai community. J Med Assoc Thai 82 (1999), 727–733.
22. Hernandez, M.B., Asher, C.R., Hernandez, A.V., et al. African American race and prevalence of atrial fibrillation: a meta-analysis. Cardiol Res Pract, 2012, 2012, 275624.
23. Dewland, T.A., Olgin, J.E., Vittinghoff, E., et al. Incident atrial fibrillation among Asians, Hispanics, blacks, and whites. Circulation 128 (2013), 2470–2477.
24. Go, A.S., Hylek, E.M., Phillips, K.A., et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study. JAMA 285 (2001), 2370–2375.
25. Oldgren, J., Healey, J.S., Ezekowitz, M., et al., for the RE-LY Atrial Fibrillation Registry Investigators, Variations in cause and management of atrial fibrillation in a prospective registry of 15,400 emergency department patients in 46 countries: the RE-LY atrial fibrillation registry. Circulation 129 (2014), 1568–1576.
26. Hobbs, F.D., Fitzmaurice, D.A., Mant, J., et al. A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study. Health Technol Assess 9 (2005), 1–74.
27. Rahman, F., Kwan, G.F., Benjamin, E.J., Global epidemiology of atrial fibrillation. Nat Rev Cardiol 11 (2014), 639–654.
28. Rizos, T., Wagner, A., Jenetzky, E., et al. Paroxysmal atrial fibrillation is more prevalent than persistent atrial fibrillation in acute stroke and transient ischemic attack patients. Cerebrovasc Dis 32 (2011), 276–282.
29. Engdahl, J., Andersson, L., Mirskaya, M., et al. Stepwise screening of atrial fibrillation in a 75-year-old population: implications for stroke prevention. Circulation 127 (2013), 930–937.
30. Svennberg, E., Engdahl, J., Al-Khalili, F., et al. Mass screening for untreated atrial fibrillation: the STROKESTOP study. Circulation 131 (2015), 2176–2184.
31. Fitzmaurice, D.A., Hobbs, F.D., Jowett, S., et al. Screening versus routine practice in detection of atrial fibrillation in patients aged 65 or over: cluster randomised controlled trial. BMJ, 335, 2007, 83.
32. Moran, P.S., Flattery, M.J., Teljeur, C., et al. Effectiveness of systematic screening for the detection of atrial fibrillation. Cochrane Database Syst Rev(4), 2013 CD009586.
33. Goldstein, L.B., Bushnell, C.D., Adams, R.J., et al., American Heart Association Stroke Council, Council on Cardiovascular Nursing, Council on Epidemiology and Prevention, Council for High Blood Pressure Research, Council on Peripheral Vascular Disease, Interdisciplinary Council on Quality of Care and Outcomes Research, Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 42 (2011), 517–584.
34. Camm, A.J., Lip, G.Y., De Caterina, R., et al., for the ESC Committee for Practice Guidelines (CPG), 2012 focused update of the ESC guidelines for the management of atrial fibrillation: an update of the 2010 ESC guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J 33 (2012), 2719–2747.
35. Kakkar, A.K., Mueller, I., Bassand, J.P., et al., for the GARFIELD Registry Investigators, Risk profiles and antithrombotic treatment of patients newly diagnosed with atrial fibrillation at risk of stroke: perspectives from the international, observational, prospective GARFIELD registry. PLoS One, 8, 2013, e63479.
36. Chiang, C.E., Naditch-Brûlé L., Murin, J., et al. Distribution and risk profile of paroxysmal, persistent, and permanent atrial fibrillation in routine clinical practice: insight from the real-life global survey evaluating patients with atrial fibrillation international registry. Circ Arrhythm Electrophysiol 5 (2012), 632–639.
37. Wanahita, N., Messerli, F.H., Bangalore, S., et al. Atrial fibrillation and obesity–results of a meta-analysis. Am Heart J 155 (2008), 310–315.
38. La Gerche, A., Schmied, C.M., Atrial fibrillation in athletes and the interplay between exercise and health. Eur Heart J 34 (2013), 3599–3602.
39. Qureshi, W.T., Alirhayim, Z., Blaha, M.J., et al. Cardiorespiratory fitness and risk of incident atrial fibrillation: results from the henry ford exercise testing (FIT) project. Circulation 131 (2015), 1827–1834.
40. Knight E. How can we avoid a stroke crisis? Working group report: stroke prevention in patients with atrial fibrillation. Available at: www.stopafib.org/newsitem.cfm. Accessed October 27, 2015.
41. Feigin, V.L., Krishnamurthi, R.V., Parmar, P., et al., for the GBD 2013 Writing Group and the GBD 2013 Stroke Panel Experts Group, Update on the global burden of ischemic and hemorrhagic stroke in 1990-2013: the GBD 2013 study. Neuroepidemiology 45 (2015), 161–176.
42. Pistoia, F., Sacco, S., Degan, D., et al. Hypertension and stroke: epidemiological aspects and clinical evaluation. High Blood Press Cardiovasc Prev, 2015 [Epub ahead of print].
43. Feigin, V.L., Lawes, C.M., Bennett, D.A., et al. Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century. Lancet Neurol 2 (2003), 43–53.
44. Sacco, S., Di Gianfilippo, G., Di Napoli, M., et al. Stroke in Italy: five-year results of the L'Aquila stroke registry (1994–1998) and comparison with comparable national and international population studies. Riv Ital Neurobiol 2 (2006), 109–136.
45. Olindo, S., Chausson, N., Mejdoubi, M., et al. Trends in incidence and early outcomes in a Black Afro-Caribbean population from 1999 to 2012: Etude Réalisée en Martinique et Centrée sur L'Incidence des Accidents Vasculaires Cérébraux II Study. Stroke 45 (2014), 3367–3373.
46. Iguchi, Y., Kimura, K., Sone, K., et al., Kurashiki Stroke Registry Investigators, Stroke incidence and usage rate of thrombolysis in a Japanese urban city: the Kurashiki stroke registry. J Stroke Cerebrovasc Dis 22 (2013), 349–357.
47. Kelly, P.J., Crispino, G., Sheehan, O., et al. Incidence, event rates, and early outcome of stroke in Dublin, Ireland. The North Dublin population stroke study. Stroke 43 (2012), 2042–2047.
48. Carolei, A., Sacco, A., De Santis, F., et al. Epidemiology of stroke. Clin Exp Hypertens 24 (2002), 479–483.
49. O'Donnell, M.J., Xavier, D., Liu, L., et al., for the INTERSTROKE Investigators, Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet 376 (2010), 112–123.
50. Bamford, J., Sandercock, P., Dennis, M., et al. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 337 (1991), 1521–1526.
51. Adams, H.P. Jr., Bendixen, B.H., Kappelle, L.J., et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of org 10172 in acute stroke treatment. Stroke 24 (1993), 35–41.
52. Andrew, N.E., Thrift, A.G., Cadilhac, D.A., The prevalence, impact and economic implications of atrial fibrillation in stroke: what progress has been made?. Neuroepidemiology 40 (2013), 227–239.
53. Sposato, L.A., Cipriano, L.E., Saposnik, G., et al. Diagnosis of atrial fibrillation after stroke and transient ischaemic attack: a systematic review and meta-analysis. Lancet Neurol 14 (2015), 377–387.
54. Arquizan, C., Lamy, C., Mas, J.L., Simultaneous supratentorial multiple cerebral infarctions. Rev Neurol 153 (1997), 748–753.
55. Bogousslavsky, J., Cachin, C., Regli, F., et al. Cardiac sources of embolism and cerebral infarction–clinical consequences and vascular concomitants: the Lausanne Stroke Registry. Neurology 41 (1991), 855–859.
56. Palacio, S., Hart, R.G., Neurologic manifestations of cardiogenic embolism: an update. Neurol Clin 20 (2002), 179–193.
57. Alzamora, M.T., Sorribes, M., Heras, A., et al., for the “ISISCOG Study Group” Ischemic stroke incidence in Santa Coloma de Gramenet (ISISCOG), Spain. A community-based study. BMC Neurol, 27(8), 2008, 5.
58. Aquil, N., Begum, I., Ahmed, A., et al. Risk factors in various subtypes of ischemic stroke according to TOAST criteria. J Coll Physicians Surg Pak 21:5 (2011), 280–283.
59. Bejot, Y., Caillier, M., Ben Salem, D., et al. Ischaemic stroke subtypes and associated risk factors: a French population based study. J Neurol Neurosurg Psychiatry 79 (2008), 1344–1348.
60. Biswas, M., Sen, S., Simmons, J., Etiology and risk factors of ischemic stroke in Indian-American patients from a hospital-based registry in New Jersey, USA. Neurol Asia 14:2 (2009), 81–86.
61. Carod-Artal, F.J., Casanova Lanchipa, J.O., Cruz Ramírez, L.M., et al. Stroke subtypes and comorbidity among ischemic stroke patients in Brasilia and Cuenca: a Brazilian-Spanish cross-cultural study. J Stroke Cerebrovasc Dis 23:1 (2014), 140–147.
62. Consoli, D., Paciaroni, M., Galati, F., et al., behalf of SISIFO Group, Prevalence of patent foramen ovale in ischaemic stroke in Italy: results of SISIFO study. Cerebrovasc Dis 39:3–4 (2015), 162–169.
63. D'Anna, L., Gigli, G.L., Gregoraci, G., et al. Identification of stroke etiology may contribute to improve the outcome in dedicated units. J Stroke Cerebrovasc Dis 24:4 (2015), 802–810.
64. Feigin, V., Carter, K., Hackett, M., et al., Auckland Regional Community Stroke Study Group, Ethnic disparities in incidence of stroke subtypes: Auckland Regional Community Stroke Study, 2002-2003. Lancet Neurol 5:2 (2006), 130–139.
65. Goldstein, L.B., Matchar, D.B., Hoff-Lindquist, J., et al. Veterans Administration Acute Stroke (VASt) Study: lack of race/ethnic-based differences in utilization of stroke-related procedures or services. Stroke 34:4 (2003), 999–1004.
66. Grau, A.J., Weimar, C., Buggle, F., et al. Risk factors, outcome, and treatment in subtypes of ischemic stroke: the German stroke data bank. Stroke 32:11 (2001), 2559–2566.
67. Gutierrez, J., Koch, S., Dong, C., et al. Racial and ethnic disparities in stroke subtypes: a multiethnic sample of patients with stroke. Neurol Sci 35:4 (2014), 577–582.
68. Hajsadeghi, S., Kashani Amin, L., Bakhshandeh, H., et al. The diagnostic value of N-terminal pro-brain natriuretic peptide in differentiating cardioembolic ischemic stroke. J Stroke Cerebrovasc Dis 22:4 (2013), 554–560.
69. Jung, K.H., Lee, S.H., Kim, B.J., et al., Korean Stroke Registry Study Group, Secular trends in ischemic stroke characteristics in a rapidly developed country: results from the Korean Stroke Registry Study (secular trends in Korean stroke). Circ Cardiovasc Qual Outcomes 5:3 (2012), 327–334.
70. Kaul, S., Sunitha, P., Suvarna, A., et al. Subtypes of ischemic stroke in a metropolitan city of South India (one year data from a hospital based stroke registry). Neurol India 50:1 (2002), 14–18.
71. Kolominsky-Rabas, P.L., Weber, M., Gefeller, O., et al. Epidemiology of ischemic stroke subtypes according to TOAST criteria: incidence, recurrence, and long-term survival in ischemic stroke subtypes: a population-based study. Stroke 32 (2001), 2735–2740.
72. Lang, Q., Zhou, M., Feng, H., et al. Research on the relationship between fibrinogen level and subtypes of the TOAST criteria in the acute ischemic stroke. BMC Neurol, 13, 2013, 207.
73. Lange, M.C., Cabral, N.L., Moro, C.H.C., et al. Incidence and mortality of ischemic stroke subtypes in Joinville, Brazil: a population-based study. Arq Neuropsiquiatr 73 (2015), 648–654.
74. Lavados, P.M., Sacks, C., Prina, L., et al. Incidence, case-fatality rate, and prognosis of ischaemic stroke subtypes in a predominantly Hispanic-Mestizo population in Iquique, Chile (PISCIS project): a community-based incidence study. Lancet Neurol 6 (2007), 140–148.
75. Leyden, J.M., Kleinig, T.J., Newbury, J., et al. Adelaide stroke incidence study: declining stroke rates but many preventable cardioembolic strokes. Stroke 44 (2013), 1226–1231.
76. Liu, X., Xu, G., Wu, W., et al. Subtypes and one-year survival of first-ever stroke in Chinese patients: the Nanjing Stroke Registry. Cerebrovasc Dis 22:2–3 (2006), 130–136.
77. Markus, H.S., Khan, U., Birns, J., et al. Differences in stroke subtypes between black and white patients with stroke: the South London ethnicity and stroke study. Circulation 116:19 (2007), 2157–2164.
78. Marnane, M., Duggan, C.A., Sheehan, O.C., et al. Stroke subtype classification to mechanism-specific and undetermined categories by TOAST, A-S-C-O, and causative classification system: direct comparison in the North Dublin population stroke study. Stroke 41 (2010), 1579–1586.
79. Medic, S., Beslac-Bumbasirevic, L., Kisic-Tepavcevic, D., et al. Short-term and long-term stroke survival: the belgrade prognostic study. J Clin Neurol 9:1 (2013), 14–20.
80. Nacu, A., Fromm, A., Sand, K.M., et al. Age dependency of ischaemic stroke subtypes and vascular risk factors in Western Norway: the Bergen Norwegian stroke Cooperation Study. Acta Neurol Scand 133:3 (2016), 202–207.
81. Nam, H.S., Kim, H.C., Kim, Y.D., et al. Long-term mortality in patients with stroke of undetermined etiology. Stroke 43:11 (2012), 2948–2956.
82. Ntaios, G., Papavasileiou, V., Makaritsis, K., et al. Association of ischaemic stroke subtype with long-term cardiovascular events. Eur J Neurol 21:8 (2014), 1108–1114.
83. Paciaroni, M., Silvestrelli, G., Caso, V., et al. Neurovascular territory involved in different etiological subtypes of ischemic stroke in the Perugia Stroke Registry. Eur J Neurol 10 (2003), 361–365.
84. Pikija, S., Cvetko, D., Malojčić B., et al. A population-based prospective 24-month study of stroke: incidence and 30-day case-fatality rates of first-ever strokes in Croatia. Neuroepidemiology 38 (2012), 164–171.
85. Porcello Marrone, L.C., Diogo, L.P., de Oliveira, F.M., et al. Risk factors among stroke subtypes in Brazil. J Stroke Cerebrovasc Dis 22:1 (2013), 32–35.
86. Renjen, P.N., Beg, M.A., Ahmad, K., Epidemiological study of incidence and risk factors of ischemic stroke subtypes according to trial of ORG 10172 in acute stroke treatment criteria: a 3 years, hospital-based study. Int J Med Public Health 5:1 (2015), 50–54.
87. Saposnik, G., Caplan, L.R., Gonzalez, L.A., et al. Differences in stroke subtypes among natives and caucasians in Boston and Buenos Aires. Stroke 31:10 (2000), 2385–2389.
88. Schulz, U.G., Rothwell, P.M., Differences in vascular risk factors between etiological subtypes of ischemic stroke: importance of population-based studies. Stroke 34 (2003), 2050–2059.
89. Sciolla, R., Ferrari, G., Leone, M., SINPAC (Società INter-regionale Piemonte e Valle d'Aosta per le Cerebrovasculopatie) Group, Stroke and transient ischaemic attack in 18 neurology departments from two Italian regions: the SINPAC database. Neurol Sci 26:4 (2005), 208–217.
90. Sen, S., Dahlberg, K., Case, A., et al. Racial-ethnic differences in stroke risk factors and subtypes: results of a prospective hospital-based registry. Int J Neurosci 123:8 (2013), 568–574.
91. Shibazaki, K., Kimura, K., Iguchi, Y., et al. Plasma brain natriuretic peptide can be a biological marker to distinguish cardioembolic stroke from other stroke types in acute ischemic stroke. Intern Med 48:5 (2009), 259–264.
92. Song, S., Burgess, R.E., Kidwell, C.S., Racial differences by ischemic stroke subtype: a comprehensive diagnostic approach. Stroke Res Treat, 2012, 2012, 735097.
93. Stead, L.G., Gilmore, R.M., Bellolio, M.F., et al. Cardioembolic but not other stroke subtypes predict mortality independent of stroke severity at presentation. Stroke Res Treat, 2011, 2011, 281496.
94. Syed, N.A., Khealani, B.A., Ali, S., et al. Ischemic stroke subtypes in Pakistan: the Aga Khan University Stroke Data Bank. J Pak Med Assoc 53:12 (2003), 584–588.
95. Toso, V., Carolei, A., Gensini, G.F., et al., SIRIO Study Investigators, The stroke in Italy and related impact on outcome (SIRIO) study: design and baseline data. Neurol Sci 27:Suppl 3 (2006), S263–S267.
96. van den Herik, E.G., de Lau, L.M., Mohamad, A., et al. Association of two single nucleotide polymorphisms from genomewide association studies with clinical phenotypes of cerebral ischemia. Int J Stroke 7:3 (2012), 219–223.
97. Zecca, B., Mandelli, C., Maino, A., et al. A bioclinical pattern for the early diagnosis of cardioembolic stroke. Emerg Med Int, 2014, 2014, 242171.
98. Hayden, D.T., Hannon, N., Callaly, E., et al. Rates and Determinants of 5-Year Outcomes After Atrial Fibrillation-Related Stroke: a Population Study. Stroke 46:12 (2015), 3488–3493.
99. Sanna, T., Diener, H.C., Passman, R.S., et al., for the CRYSTAL AF Investigators, Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med 370 (2014), 2478–2486.
100. Gladstone, D.J., Spring, M., Dorian, P., et al., for the EMBRACE Investigators and Coordinators, Atrial fibrillation in patients with cryptogenic stroke. N Engl J Med 370 (2014), 2467–2477.